| Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ... The Lancet Neurology 17 (2), 162-173, 2018 | 7575 | 2018 |
| Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome DT Okuda, EM Mowry, A Beheshtian, E Waubant, SE Baranzini, ... Neurology 72 (9), 800-805, 2009 | 773 | 2009 |
| Vitamin D status is associated with relapse rate in pediatric‐onset multiple sclerosis EM Mowry, LB Krupp, M Milazzo, D Chabas, JB Strober, AL Belman, ... Annals of neurology 67 (5), 618-624, 2010 | 455 | 2010 |
| Long‐term evolution of multiple sclerosis disability in the treatment era University of California, San Francisco MS‐EPIC Team:, BAC Cree, ... Annals of neurology 80 (4), 499-510, 2016 | 435 | 2016 |
| Gut microbiota in multiple sclerosis: possible influence of immunomodulators BL Cantarel, E Waubant, C Chehoud, J Kuczynski, TZ DeSantis, ... Journal of Investigative Medicine 63 (5), 729-734, 2015 | 415 | 2015 |
| Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis EM Mowry, E Waubant, CE McCulloch, DT Okuda, AA Evangelista, ... Annals of neurology 72 (2), 234-240, 2012 | 352 | 2012 |
| Environmental and genetic risk factors for MS: an integrated review E Waubant, R Lucas, E Mowry, J Graves, T Olsson, L Alfredsson, ... Annals of clinical and translational neurology 6 (9), 1905-1922, 2019 | 332 | 2019 |
| Multiple sclerosis progression: time for a new mechanism-driven framework T Kuhlmann, M Moccia, T Coetzee, JA Cohen, J Correale, J Graves, ... The Lancet Neurology 22 (1), 78-88, 2023 | 313 | 2023 |
| Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome DT Okuda, EM Mowry, BAC Cree, EC Crabtree, DS Goodin, E Waubant, ... Neurology 76 (8), 686-692, 2011 | 288 | 2011 |
| Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer TJ Williams, DR Benavides, KA Patrice, JO Dalmau, ALR De Ávila, DT Le, ... JAMA neurology 73 (8), 928-933, 2016 | 274 | 2016 |
| Common viruses associated with lower pediatric multiple sclerosis risk E Waubant, EM Mowry, L Krupp, T Chitnis, EA Yeh, N Kuntz, J Ness, ... Neurology 76 (23), 1989-1995, 2011 | 209 | 2011 |
| Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults E Waubant, D Chabas, DT Okuda, O Glenn, E Mowry, RG Henry, ... Archives of neurology 66 (8), 967-971, 2009 | 204 | 2009 |
| Cell-based therapeutic strategies for multiple sclerosis NJ Scolding, M Pasquini, SC Reingold, JA Cohen Brain 140 (11), 2776-2796, 2017 | 191 | 2017 |
| Safety and immunologic effects of high-vs low-dose cholecalciferol in multiple sclerosis ES Sotirchos, P Bhargava, C Eckstein, K Van Haren, M Baynes, A Ntranos, ... Neurology 86 (4), 382-390, 2016 | 184 | 2016 |
| Gut microbiome and multiple sclerosis P Bhargava, EM Mowry Current neurology and neuroscience reports 14, 1-8, 2014 | 166 | 2014 |
| Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation P Bhargava, MD Smith, L Mische, E Harrington, KC Fitzgerald, K Martin, ... The Journal of clinical investigation 130 (7), 3467-3482, 2020 | 157 | 2020 |
| Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity EM Mowry, MJ Loguidice, AB Daniels, DA Jacobs, CE Markowitz, ... Journal of Neurology, Neurosurgery & Psychiatry 80 (7), 767-772, 2009 | 157 | 2009 |
| Multiple sclerosis risk factors and pathogenesis B Nourbakhsh, EM Mowry CONTINUUM: Lifelong Learning in Neurology 25 (3), 596-610, 2019 | 153 | 2019 |
| Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype? D Chabas, T Castillo-Trivino, EM Mowry, JB Strober, OA Glenn, ... Neurology 71 (14), 1090-1093, 2008 | 146 | 2008 |
| Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial B Nourbakhsh, N Revirajan, B Morris, C Cordano, J Creasman, ... The Lancet Neurology 20 (1), 38-48, 2021 | 145 | 2021 |
